Clinical Trial

The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

Study acronym: CAT-RA
Recruiting
View on ClinicalTrials.gov →
Summary
Individuals with rheumatoid arthritis (RA) have up to 2x the risk of having a heart attack compared to someone without RA. The goal of this study is to identify biomarkers that can help us do a better job of identifying individuals at risk before they develop symptoms of heart disease and start preventative treatment earlier.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-31.
Trial Details
NCT Number NCT07315997
Lead Sponsor Brigham and Women's Hospital
Collaborators: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions Rheumatoid Arthritis (RA, Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment 120 participants
Start Date 2024-09-04
Primary Completion 2028-03-04 (estimated)
Study Completion 2028-03-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-14